NCT06110117View on ClinicalTrials.gov

Assess Efficacy and Safety of a Nasal Spray in Adults With Dry or Irritated Nose

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 27, 2023

Primary Completion Date

March 15, 2024

Study Completion Date

November 4, 2024

Conditions
Dry Nose
Interventions
DEVICE

Sterimar Stop & Protect Irritation & Dryness

One or two nasal sprays will be administered to each nostril for a minimum of 2 times per day up to a maximum of 6 times per day for seven days.

Trial Locations (2)

80-288

Eurofins Dermscan Poland, Gdansk

80-400

Centrum medyczne, Sztum

All Listed Sponsors
lead

Church & Dwight Company, Inc.

INDUSTRY

NCT06110117 - Assess Efficacy and Safety of a Nasal Spray in Adults With Dry or Irritated Nose | Biotech Hunter | Biotech Hunter